Related Terms

• Consumptive's weed, bear's weed, eriodictyol, Eriodictyon californicum, Eriodictyon glutinosum, gum bush, holy herb, mountain balm, sacred herb, tarweed, Wigandia californicum.

• Note: Not to be confused with other herbs which share the same common name(s). For example, the common name "mountain balm" is also used for Ceanothus velutinus, Satureja chandleri, and Calamintha nepeta. The common name "consumptive's weed" is associated with three different Eriodictyon species. The common name "gum bush" is also associated with several different Eriodictyon species. The common name "bear's weed" is also used for Arctostaphylos uva-ursi. The common name "tarweed" is associated with many species of Hemizonia and Madia. The common name "holy herb" is used for marijuana (Cannabis sativa), hyssop (Sorghum vulgare), basil (Ocimum basilicum), verbena (Verbena officinalis) and aloe (Aloe barbadensis). The common name "Sacred herb" is used for marijuana and tobacco (Nicotiana tabacum).

Background

• Chumash Indians and other California Indians have used yerba santa (Eriodictyon californicum) and other related species (Eriodictyon crassifolium, Eriodictyon trichocalyx) for many centuries in the treatment of pulmonary (lung) conditions, saliva production, and to stop bleeding of minor cuts and scrapes.

• In the United States and Britain, Eriodictyon californicum was formally used for conditions including influenza, bacterial pneumonia, asthma, bronchitis, and tuberculosis starting in the late 1800s until the 1960s (when drug regulations became more stringent around proof of efficacy). Subsequently, the extracts remained GRAS ("generally regarded as safe") as a flavor for foods, beers, and pharmaceuticals (such as to hide the bitterness of quinine). Eriodictyon plant extracts have also been used in cosmetics.

• Eriodictyon species contain flavones with free radical scavenging (antioxidant) properties, and have therefore been proposed as being beneficial for a number of health conditions. However, there is little scientific study of yerba santa in humans, and effectiveness has not been demonstrated for any specific condition.

Scientific Evidence

Tradition/Theory

The below uses are based on tradition or scientific theories. They often have not been thoroughly tested in humans, and safety and effectiveness have not always been proven. Some of these conditions are potentially serious and should be evaluated by a qualified health care professional.

• Allergies, antibacterial, antifungal, anti-inflammatory, anti-parasitic, antioxidant, antiviral, arthritis, asthma, blood coagulation disorders, cancer, cosmetics, dry mouth, excipient (inactive ingredient) for drug delivery, food flavoring, hypercholesterolemia (high cholesterol), hypertension (high blood pressure), malaria, saliva production, skin scrapes, smooth muscle relaxant, tuberculosis, urinary tract infections.

Dosing

The below doses are based on scientific research, publications, traditional use, or expert opinion. Many herbs and supplements have not been thoroughly tested, and safety and effectiveness may not be proven. Brands may be made differently, with variable ingredients, even within the same brand. The below doses may not apply to all products. You should read product labels, and discuss doses with a qualified healthcare provider before starting therapy.

Adults (18 years and older)

• There is no proven safe or effective dose for yerba santa in adults. Traditionally, 1-2 milliliters of fluid extract has been taken by mouth with a spoon every 3-4 hours for no more than ten days.

• Poultices have been made by crushing 0.2 kilograms of the leaves in 1,000 milliliters of water. The leaves have been used traditionally as a treatment for pulmonary (lung) congestion by placing the slightly wet leaves on the chest. The poultice is usually used once or twice every day for up to two weeks.

Children (younger than 18 years)

• There is no proven safe or effective dose for yerba santa in children. Traditionally, 1 milliliter of the alcohol extract has been used in children. Caution is warranted in children due to the presence of ethanol. Poultices have also been applied on the skin.

Safety

The U.S. Food and Drug Administration does not strictly regulate herbs and supplements. There is no guarantee of strength, purity or safety of products, and effects may vary. You should always read product labels. If you have a medical condition, or are taking other drugs, herbs, or supplements, you should speak with a qualified healthcare provider before starting a new therapy. Consult a healthcare provider immediately if you experience side effects.

Allergies

• Avoid in individuals with a known allergy or hypersensitivity to Eriodictyon species.

Side Effects and Warnings

• There are no published reports of toxicity clearly attributable to yerba santa (Eriodictyoncalifornicum), although this herb has been used for centuries by California Indians with a belief in its safety. However, there are no available scientific evaluations of toxicity or safety.

Pregnancy and Breastfeeding

• Yerba santa is not recommended in pregnant or breastfeeding women due to a lack of available scientific evidence.

Interactions

Most herbs and supplements have not been thoroughly tested for interactions with other herbs, supplements, drugs, or foods. The interactions listed below are based on reports in scientific publications, laboratory experiments, or traditional use. You should always read product labels. If you have a medical condition, or are taking other drugs, herbs, or supplements, you should speak with a qualified healthcare provider before starting a new therapy.

Interactions with Drugs

• The flavonoids homoeriodictyol and eriodictyol found in yerba santa may interfere with the way the body processes certain drugs using the liver's "cytochrome P450" enzyme system. As a result, the levels of these drugs may be increased in the blood, and may cause increased effects or potentially serious adverse reactions. Patients using any medications should check the package insert, and speak with a qualified healthcare professional, including a pharmacist, about possible interactions.

Interactions with Herbs and Dietary Supplements

• The flavonoids homoeriodictyol and eriodictyol found in yerba santa may interfere with the way the body processes certain herbs or supplements using the liver's "cytochrome P450" enzyme system. As a result, the levels of other herbs or supplements may become too high in the blood. It may also alter the effects that other herbs or supplements possibly have on the P450 system.

Author Information

• This information is based on a systematic review of scientific literature edited and peer-reviewed by contributors to the Natural Standard Research Collaboration (www.naturalstandard.com).

References

Natural Standard developed the above evidence-based information based on a thorough systematic review of the available scientific articles. For comprehensive information about alternative and complementary therapies on the professional level, go to www.naturalstandard.com. Selected references are listed below.

1. Ahmed MS, Galal AM, Ross SA, et al. A weakly antimalarial biflavanone from Rhus retinorrhoea. Phytochemistry 2001;58(4):599-602. View Abstract

2. Doostdar H, Burke MD, Mayer RT. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicology 2000;144(1-3):31-38. View Abstract

3. Gradolatto A, Basly J, Berges R, et al. Pharmacokinetics and metabolism of apigenin in female and male rats after a single oral administration. Drug Metab Dispos 2005;33:49-54.

4. Grael CF, Vichnewski W, Souza GE, et al. A study of the trypanocidal and analgesic properties from Lychnophora granmongolense (Duarte) Semir & Leitao Filho. Phytother Res 2000;14(3):203-206. View Abstract

5. Huguet AI, Manez S, Alcaraz MJ. Superoxide scavenging properties of flavonoids in a non-enzymic system. Z Naturforsch [C ] 1990;45(1-2):19-24. View Abstract

6. Ko WC, Shih CM, Lai YH, et al. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships. Biochem Pharmacol 2004;68(10):2087-2094. View Abstract

7. Konstantinopoulou M, Karioti A, Skaltsas S, et al. Sesquiterpene lactones from Anthemis altissima and their anti-Helicobacter pylori activity. J Nat Prod 2003;66(5):699-702. View Abstract

8. Liu YL, Ho DK, Cassady JM, et al. Isolation of potential cancer chemopreventive agents from Eriodictyon californicum. J Nat Prod 1992;55(3):357-363. View Abstract

9. Matsuda H, Morikawa T, Toguchida I, et al. Medicinal flowers. VI. Absolute stereostructures of two new flavanone glycosides and a phenylbutanoid glycoside from the flowers of Chrysanthemum indicum L.: their inhibitory activities for rat lens aldose reductase. Chem Pharm Bull (Tokyo) 2002;50(7):972-975. View Abstract

10. Matsuo M, Sasaki N, Saga K, et al. Cytotoxicity of flavonoids toward cultured normal human cells. Biol Pharm Bull 2005;28(2):253-259. View Abstract

11. Rechner AR, Smith M, Kuhnle F, et al. Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products. Free Rad Biol Med 2004;36:212-225.

12. 'T Hart BA, Ip Via Ching TR, Van Dijk H, et al. How flavonoids inhibit the generation of luminol-dependent chemiluminescence by activated human neutrophils. Chem Biol Interact 1990;73(2-3):323-335. View Abstract

13. Thiyagarajah P, Kuttan SC, Lim SC, et al. Effect of myricetin and other flavonoids on the liver plasma membrane Ca2+ pump. Kinetics and structure-function relationships. Biochem Pharmacol 1991;41(5):669-675. View Abstract

14. Tsimogiannis D, Oreopoulou V. Free radical scavenging and antioxidant activity of 5,7,3',4'-hydroxy substituted flavonoids. Inn Food Sci Emerg Tech 2004;5:523-528.

15. van Zanden JJ, Geraets L, Wortelboer HM, et al. Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells. Biochem Pharmacol 2004;67(8):1607-1617. View Abstract